CD8A and neoplasm: The results showed that the tumor growth was significantly inhibited after αMSLN treatment (p < 0.0001), accompanied by significant infiltration of CD3+ and CD8+ T cells (p < 0.0001 and p = 0.0003, respectively, Figure S2B‐G, Supporting Information).